Thomas D.Y. Chung
Director, Translational Programs Outreach, Sanford Burnham Prebys Medical Discovery Institute
Thomas D.Y. Chung is listed as Director, Translational Programs Outreach, Sanford Burnham Prebys Medical Discovery Institute. Thomas is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Thomas. Is this you? Claim this profile.
About
Thomas "TC" Chung is Dir of Translational Programs Outreach at Sanford Burnham Prebys Medical Discovery Institute and was formerly Assoc Dir of the Office of Translation to Practice at the Mayo Clinic. Dr. Chung is responsible for strategic alliances & translational research development. He has over 25 years from bench R&D to executive leadership in several pharma companies exiting as biotech Chief Scientific Officer. He has built world-class facilities and led R&D teams that developed, acquired and integrated novel technologies in imaging, signal generation and detection, liquid handling, miniaturization, IT, high-throughput screening, biochemical and cell-based assay development, laboratory automation and robotics, compound management, Lead optimization, ADME/Tox profiling and analytical chemistry (HPLC/MS). He has managed discovery programs in cardiovascular, CNS, infectious, inflammatory and cancer diseases, leveraging his expertise in biochemistry, molecular
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Thomas at events on B2DB.
- Benjamin Bader Director / Head of Screening · Nuvisan 1 shared session
- Jayme Dahlin Medical Director, Clinical Development · Oruka Therapeutics 1 shared session
- Joe Trask Life Sciences Segment Manager, NA · Revvity 1 shared session
- Michelle Arkin Professor, Pharm Chem; co-Director, Small Molecule Discovery Center · University of California - San Francisco 1 shared session
- Nathan Coussens Scientific Director, Molecular Pharmacology Laboratory · Frederick National Laboratory for Cancer Research 1 shared session
- Sarine Markossian Editor-in-Chief, Assay Guidance Manual (AGM) and Lead, AGM Translational Science Resources Program · NCATS/NIH 1 shared session
- Stefan Grotegut Executive Director, High-Throughput Screening · Eli Lilly and Company 1 shared session
- Terry Riss Scientific Ambassador · Promega Corporation 1 shared session